2012 Midyear Clinical Meeting
Click here to go to the previous page
Troubled Teen 101: Topics in Adolescent Psychiatry
Track:
Education Sessions (CE)
Program Code: 283-L01
Date: Wednesday, December 5, 2012
Time: 8:00 AM to 9:45 AM EST
Location:
South Seas H, Level 3, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
|
Dr. Dopheide is an Associate Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California Schools of Pharmacy, and Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.
Dr. Dopheides clinical practice is divided between adults, adolescents and children with psychiatric illness. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse. She routinely counsels patients and families on how to get the most benefit with the least side effects from their psychotropic medications.
Dr. Dopheide is actively involved in the advancement of the pharmacy profession through her work with the College of Psychiatric and Neurologic Pharmacists (CPNP), the American Society of Health System Pharmacists (ASHP) and through collaboration with the National Alliance of the Mentally (NAMI).
Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. She has over 40 publications on topics in psychopharmacology and clinical pharmacy. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.
|
Elizabeth Sowell,
PhD, Professor of Pediatrics,
University of Southern California/Children's Hospital Los Angeles
|
I am Professor of Pediatrics at the University of Southern California/Childrens Hospital Los Angeles, and the director of the Developmental Cognitive Neuroimaging Laboratory. I received my Ph.D. from the University of California, San Diego/San Diego State University Joint Doctoral program in Clinical Psychology (Neuropsychology) in 1997. I completed an NIMH postdoctoral fellowship in UCLAs Laboratory of Neuro Imaging where I specialized in advanced image analysis technology in developmental populations. My research has focused on multi-modal magnetic resonance imaging and neurocognitive correlates of normative brain development and brain morphologic abnormalities in children with various neurodevelopmental disorders such as fetal alcohol syndrome and attention-deficit hyperactivity disorder with over 50 peer reviewed journal articles (now cited over 4,500 times, h-index, 30) in her field. I have been the recipient of numerous NIH awards (K01, R21, U24, R01, U01), including awards from NIDA to conduct longitudinal studies of children with prenatal methamphetamine exposure using functional and structural neuroimaging, NICHD to conduct multimodal image analyses in typically developing children, and from NIAAA to conduct a multi-site imaging study on the effects of prenatal exposure to alcohol, and NICHD to study children with perinatally acquired HIV. I have been the PI of the Brain Imaging Project of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) over the last 7 years.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
|
Dr. Dopheide is an Associate Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences at the University of Southern California Schools of Pharmacy, and Medicine. She is actively involved in teaching pharmacy students, medical students and psychiatry and pharmacy residents through didactic and clinical teaching.
Dr. Dopheides clinical practice is divided between adults, adolescents and children with psychiatric illness. As part of a multidisciplinary treatment team, Dr. Dopheide makes recommendations to optimize treatment for psychiatric illnesses including schizophrenia, mood disorders, anxiety, attention-deficit hyperactivity disorder, chronic insomnia and substance abuse. She routinely counsels patients and families on how to get the most benefit with the least side effects from their psychotropic medications.
Dr. Dopheide is actively involved in the advancement of the pharmacy profession through her work with the College of Psychiatric and Neurologic Pharmacists (CPNP), the American Society of Health System Pharmacists (ASHP) and through collaboration with the National Alliance of the Mentally (NAMI).
Dr. Dopheide obtained her PharmD from the University of Nebraska College of Pharmacy in Omaha and went on to complete a residency in Psychiatric Pharmacy Practice at the University of Southern California Medical Center. She has over 40 publications on topics in psychopharmacology and clinical pharmacy. A Nebraska native, she now considers Southern California her home and enjoys rooting for both the Cornhuskers and the Trojans during football season.
|
Description
Case Presentation, Julie Dopheide, PharmD, BCPP
The Adolescent Brain, Elizabeth Sowell, PhD
Recognizing and Managing Psychiatric Disorders in Youth, Julie Dopheide, PharmD, BCPP
- Explain how the development of the brain progresses from childhood into adulthood and how this ongoing brain development impacts attention, mood and behavior.
- Given a case of an adolescent prescribed an antipsychotic, mood stabilizer or antidepressant, determine which adverse effects are most problematic and recommend management and counseling.
- Recognize signs and symptoms of psychiatric disorders, including ADHD, substance abuse, eating disorders, mood and psychotic disorders, in adolescents.
